|
10DV
Room Temperature X-Ray Structure of SARS CoV-2 Main Protease Intermediate Precursor with Ensitrelvir (ESV)
Deposited 2026-01-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
304–357(54 aa)
Chain B
304–357(54 aa)
|
Mutation:C145A
Mutation:C145A
|
7YY 6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-[(1-methyl-1,2,4-triazol-3-yl)methyl]-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;18-21% PEG3350, 0.1 M Bis-Tris, pH 6.5 or 7.0
|
Resolution 2.05 Å
R-free 0.234
|
|
1FCC
CRYSTAL STRUCTURE OF THE C2 FRAGMENT OF STREPTOCOCCAL PROTEIN G IN COMPLEX WITH THE FC DOMAIN OF HUMAN IGG
Deposited 1995-01-17
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
372–427(56 aa)
Chain D
372–427(56 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 3.20 Å
R-free 0.357
|
|
1FCL
DELTA1.5: A COMPUTATIONALLY DESIGNED CORE VARIANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G
Deposited 2000-07-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
Fragment:GB1_DELTA1.5
|
Mutation:Y3F, L7I, F30L, A34I, V39I, F52W
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;298 K;Ionic strength (raw mmCIF value) 50 mM sodium phosphate;Pressure Atmospheric
NMR sample composition
1 mM unlabeled protein in 50 mM sodium phosphate, pH 6.0 | either D2O or 90:10 H2O:D2O
|
Resolution not provided
|
|
1FD6
DELTA0: A COMPUTATIONALLY DESIGNED CORE VARIANT OF THE B1 DOMAIN OF STREPTOCOCCAL PROTEIN G
Deposited 2000-07-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
Fragment:GB1_DELT0
|
Mutation:Y3F, L7I, V39I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;298 K;Ionic strength (raw mmCIF value) 50 mM sodium phosphate;Pressure ambient
NMR sample composition
3 mM protein in 50 mM sodium phosphate, pH 6.0 | either D2O or 90:10 H2O:D2O
|
Resolution not provided
|
|
1GB4
HYPERTHERMOPHILIC VARIANT OF THE B1 DOMAIN FROM STREPTOCOCCAL PROTEIN G, NMR, 47 STRUCTURES
Deposited 1998-01-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
372–427(56 aa)
Fragment:B1 DOMAIN
|
Mutation:V1M, Y4F, V7I, T17I, T19I, T26E, V30I, V40I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5;308 K;Ionic strength (raw mmCIF value) 50mM;Pressure ATMOSPHERIC
NMR sample composition
H2O/D2O
|
Resolution not provided
|
|
1GJS
Solution structure of the Albumin binding domain of Streptococcal Protein G
Deposited 2001-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
254–299(46 aa)
Fragment:ALBUMIN-BINDING DOMAIN RESIDUES 254-299
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;300 K;Pressure 1
|
Resolution not provided
|
|
1GJT
Solution structure of the Albumin binding domain of Streptococcal Protein G
Deposited 2001-08-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
254–299(46 aa)
Fragment:ALBUMIN-BINDING DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.2;300 K;Pressure 1
|
Resolution not provided
|
|
1IBX
NMR STRUCTURE OF DFF40 AND DFF45 N-TERMINAL DOMAIN COMPLEX
Deposited 2001-03-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
302–357(56 aa)
Fragment:B1 DOMAIN OF PROTEIN G FUSED WITH N-TERMINAL DOMAIN (CIDE DOMAIN) OF DFF45
|
Mutation:T(-43)Q
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6;296 K;Ionic strength (raw mmCIF value) 50 mM NaCl;Pressure ambient
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex 90% deuterated, U-15N/13C labeled DFF40 non-labeled DFF45 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex U-13C labeled DFF45 non-labeled DFF40 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl D2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex 90% deuterated, U-15N/13C labeled DFF45 non-labeled DFF40 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex U-15N labeled DFF40 non-labeled DFF45 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex U-15N labeled DFF45 non-labeled DFF40 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex perdeuterated, U-15N labeled DFF40 non-labeled DFF45 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex perdeuterated, U-15N labeled DFF45 non-labeled DFF40 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex 10% 13C labeled DFF40 non-labeled DFF45 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex 10% 13C labeled DFF45 non-labeled DFF40 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl 10%D2O/90%H2O
NMR sample composition
0.6 mM DFF40/DFF45 NTD complex U-13C labeled DFF40 non-labeled DFF45 | 20 mM Phosphate buffer 5 mM DTT, 50 mM NaCl D2O
|
Resolution not provided
|
|
1P7E
GB3 solution structure obtained by refinement of X-ray structure with dipolar couplings
Deposited 2003-05-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
444–497(54 aa)
Fragment:THIRD IGG-BINDING DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;300 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient
NMR sample composition
25 mM NaH2PO4/Na2HPO4, 0.2 mg/mL NaN3, 1.5 mM GB3 protein and aligning media
|
Resolution not provided
|
|
1P7F
GB3 solution structure obtained by refinement of X-ray structure with dipolar couplings
Deposited 2003-05-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
444–497(54 aa)
Fragment:THIRD IGG-BINDING DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;300 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient
NMR sample composition
25 mM NaH2PO4/Na2HPO4, 0.2 mg/mL NaN3, 1.5 mM GB3 protein and aligning media
|
Resolution not provided
|
|
1ZXH
G311 mutant protein
Deposited 2005-06-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
443–497(55 aa)
|
Mutation:yes
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;275 K;Ionic strength (raw mmCIF value) 0.1M;Pressure ambient
NMR sample composition
G311 mutant protein, 0.1 M KPi, pH7.0, ~0.6 M GuHCl. | 0.1 M KPi, pH7.0, ~0.6 M GuHCl.
|
Resolution not provided
|
|
2GI9
Backbone Conformational Constraints in a Microcrystalline U-15N-Labeled Protein by 3D Dipolar-Shift Solid-State NMR Spectroscopy
Deposited 2006-03-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:T2Q
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.5;5mM Acetate 3.8, 150mM NaCl, 50% MPD and 20% IPA, pH 4.5
|
Resolution 1.14 Å
R-free 0.181
|
|
2I2Y
Solution structure of the RRM of SRp20 bound to the RNA CAUC
Deposited 2006-08-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain A
304–357(54 aa)
Fragment:RRM domain
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.4;315 K;Pressure ambient
NMR sample composition
1mM SRp20 13C-15N labelled + 1 mM CAUC natural abundance in 50 mM sodium dihydrogenophosphate, pH 6.4, 1mM DTT; | 10% D2O,90% H2O
or 100% D2O
NMR sample composition
1mM SRp20 15N labelled + 1 mM CAUC natural abundance in 1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 6.4, 1mM DTT | 10% D2O, 90% H2O
or 100% D2O
NMR sample composition
1mM SRp20 15N labelled + 1 mM CAUC with 13C labelled riboses and natural abundance bases in 50 mM sodium dihydrogenophosphate, pH 6.4, 1mM DTT; | 10% D2O, 90% H2O
or 100% D2O
NMR sample composition
1mM SRp20 15N labelled + 1 mM CAUC with A2 and U3 riboses 13C labelled and natural abundance of other riboses and all bases in 50 mM sodium dihydrogenophosphate, pH 6.4, 1mM DTT; | 10% D2O, 90% H2O
or 100% D2O
NMR sample composition
1mM SRp20 15N labelled + 1 mM CAUC with C1 and C4 riboses 13C labelled and natural abundance of other riboses and all bases, in 50 mM sodium dihydrogenophosphate, pH 6.4, 1mM DTT; | 10% D2O, 90% H2O
or 100% D2O
|
Resolution not provided
|
|
2I38
Solution structure of the RRM of SRp20
Deposited 2006-08-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:RRM domain
|
Mutation:E129D
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.8;315 K;Pressure ambient
NMR sample composition
1mM SRp20 13C-15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT; | 10% D2O, 90% H2O
or 100% D2O
NMR sample composition
1mM SRp20 15N labelled in 50 mM sodium dihydrogenophosphate, pH 5.8, 1mM DTT; | 10% D2O, 90% H2O
or 100% D2O
|
Resolution not provided
|
|
2IGG
DETERMINATION OF THE SOLUTION STRUCTURES OF DOMAINS II AND III OF PROTEIN G FROM STREPTOCOCCUS BY 1H NMR
Deposited 1992-08-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
367–430(64 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
mmCIF provides none of the parsed conditions
|
Resolution not provided
|
|
2JSV
Dipole tensor-based refinement for atomic-resolution structure determination of a nanocrystalline protein by solid-state NMR spectroscopy
Deposited 2007-07-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
303–357(55 aa)
Fragment:2-1 repeat
|
Mutation:T2Q
|
No recorded non-water small molecule
|
SOLID-STATE NMR
NMR measurement conditions
pH 5.5;281 K;Pressure ambient
NMR sample composition
14 mg/mL [U-99% 13C; U-99% 15N] protein, (4R)-2-Metylpentane-2,4-Diol (50% v/v), Isopropyl alcohol (25% v/v), 25 mg/mL GB1 in 50 mM sodium phosphate buffered H2O | H2O
NMR sample composition
14 mg/mL [U-99% 15N] protein, (4R)-2-Metylpentane-2,4-Diol (50% v/v), Isopropyl alcohol (25% v/v), 25 mg/mL GB1 in 50 mM sodium phosphate buffered H2O | H2O
NMR sample composition
14 mg/mL [U-100% 13C; U-100% 15N] protein, (4R)-2-Metylpentane-2,4-Diol (50% v/v), Isopropyl alcohol (25% v/v), 25 mg/mL GB1 in 50 mM sodium phosphate buffered H2O | H2O
NMR sample composition
14 mg/mL (1,3) 13C glycerol, U15N protein, (4R)-2-Metylpentane-2,4-Diol (50% v/v), Isopropyl alcohol (25% v/v), 25 mg/mL GB1 in 50 mM sodium phosphate buffered H2O | H2O
NMR sample composition
14 mg/mL 2 13C glycerol, Uniform 15N protein, (4R)-2-Metylpentane-2,4-Diol (50% v/v), Isopropyl alcohol (25% v/v), 25 mg/mL GB1 in 50 mM sodium phosphate buffered H2O | H2O
|
Resolution not provided
|
|
2KHU
Solution Structure of the Ubiquitin-Binding Motif of Human Polymerase Iota
Deposited 2009-04-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357, 676-715
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;25 K;Ionic strength (raw mmCIF value) 0.1;Pressure ambient
NMR sample composition
1-4 mM [U-100% 13C; U-100% 15N] D2O-1, 1-4 mM [U-100% 13C; U-100% 15N] H2O-2, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2KHW
Solution Structure of the human Polymerase iota UBM2-Ubiquitin Complex
Deposited 2009-04-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357, 676-715
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR sample composition
1 mM [U-100% 15N] entity_1-1, 4 mM entity_2-2, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
3 mM [U-100% 15N] entity_1-3, 3 mM [U-100% 15N] entity_2-4, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
3 mM [U-100% 13C; U-100% 15N] entity_1-5, 3 mM [U-100% 13C; U-100% 15N] entity_2-6, 100% D2O | 100% D2O
NMR sample composition
1 mM [U-100% 13C; U-100% 15N] entity_1-7, 4 mM entity_2-8, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2KN4
The structure of the RRM domain of SC35
Deposited 2009-08-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357 from P19909, UNP residues 9-101 from Q01130
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.8;305 K;Ionic strength (raw mmCIF value) 100;Pressure ambient
NMR sample composition
0.5 mM [U-100% 13C; U-100% 15N] SC35-1, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-100% 13C; U-100% 15N] SC35-2, 100% D2O | 100% D2O
NMR sample composition
0.5 mM [U-100% 15N] SC35-3, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM SC35-4, 100% D2O | 100% D2O
|
Resolution not provided
|
|
2KQ4
Atomic resolution protein structure determination by three-dimensional transferred echo double resonance solid-state nuclear magnetic resonance spectroscopy
Deposited 2009-10-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
303–357(55 aa)
Fragment:UNP residues 303 to 357
|
Mutation:T2Q
|
No recorded non-water small molecule
|
SOLID-STATE NMR
NMR measurement conditions
Pressure ambient
NMR sample composition
30 mg 1,3-13C glycerol, U 15N entity-1, 50 v/v MPTG-2, solid | solid
NMR sample composition
30 mg 2-13C glycerol, U 15N entity-3, 50 v/v MPTG-4, solid | solid
|
Resolution not provided
|
|
2KWD
Supramolecular Protein Structure Determination by Site-Specific Long-Range Intermolecular Solid State NMR Spectroscopy
Deposited 2010-04-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 5
PDB declaration: pentameric
|
Chain A
304–357(54 aa)
Chain B
304–357(54 aa)
Chain C
304–357(54 aa)
Chain D
304–357(54 aa)
Chain E
304–357(54 aa)
|
Mutation:T2Q
Mutation:T2Q
Mutation:T2Q
Mutation:T2Q
Mutation:T2Q
|
No recorded non-water small molecule
|
SOLID-STATE NMR
NMR measurement conditions
273 K;Pressure 1
NMR sample composition
20 mg [U-1,3-13C-glycerol; U-100% 15N] GB1-1, solid | solid
NMR sample composition
50 % [U-1,3-13C-glycerol] GB1-2, 50 % [U-99% 15N] GB1-3, solid | solid
NMR sample composition
20 mg [U-2-13C-glycerol; U-100% 15N] GB1-4, solid | solid
|
Resolution not provided
|
|
2LUM
Three-State Ensemble obtained from eNOEs of the Third Immunoglobulin Binding Domain of Protein G (GB3)
Deposited 2012-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
444–497(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient
NMR sample composition
4 mM [U-95% 13C; U-95% 15N] Third Immunoglobulin G-binding protein G, 50 mM potassium phosphate, 0.5 mg/mL sodium azide, 50 mM sodium chloride, 97% H2O/3% D2O | 97% H2O/3% D2O
|
Resolution not provided
|
|
2N9K
1H, 13C, and 15N Chemical Shift Assignments for in vitro GB1
Deposited 2015-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
Fragment:UNP residues 303-357
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;295 K;Ionic strength (raw mmCIF value) 0.31;Pressure ambient
NMR sample composition
1 mM [U-100% 13C; U-100% 15N] Protein G B1-1, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2N9L
1H, 13C, and 15N Chemical Shift Assignments for in-cell GB1
Deposited 2015-11-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
Fragment:UNP residues 303-357
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;295 K;Ionic strength (raw mmCIF value) 0.31;Pressure ambient
NMR sample composition
250 uM [U-100% 13C; U-100% 15N] Protein G B1-1, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2OED
GB3 solution structure obtained by refinement of X-ray structure with dipolar couplings
Deposited 2006-12-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
444–497(54 aa)
Fragment:THIRD IGG-BINDING DOMAIN
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;300 K;Ionic strength (raw mmCIF value) 0.05;Pressure ambient
NMR sample composition
25 MM NAH2PO4/NA2HPO4, 0.2 MG/ML NAN3, 1.5 MM GB3 PROTEIN AND ALIGNING MEDIA, 90% H2O, 10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
2ON8
Gbeta1 stabilization by in vitro evolution and computational design
Deposited 2007-01-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
|
Mutation:T1M, T2Q, Y3F, V6I, T16I, T18L, T25E, V29K, V39I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;50mM Na acetate, pH 5.0, 17 mg/ml protein mixed with equal volume of 2.3M ammonium suphate, 0.1M sodium acetate, pH 4.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.35 Å
R-free 0.195
|
|
2ONQ
Gbeta1 stabilization by in vitro evolution and computational design
Deposited 2007-01-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:residues 373-427
|
Mutation:T2Q, Y3F, L7I, T16I, T18I, T25E, V29F, V39I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5;293.15 K;50mM sodium acetate, 20mg/ml protein solution mixed in equal volume of crystallization buffer containing
33% PEG monomethylether, 0.1M calcium chloride, pH 5.0, VAPOR DIFFUSION, SITTING DROP, temperature 293.15K
|
Resolution 1.70 Å
R-free 0.229
|
|
2PLP
Ultra high resolution backbone conformation of protein GB1 from residual dipolar couplings alone
Deposited 2007-04-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–356(54 aa)
Fragment:First Immunoglobin binding domain (GB1)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.6;300 K;Ionic strength (raw mmCIF value) 50mM salt;Pressure ambient
NMR sample composition
perdeuterated (triple labelled 15N, 13C, 2D) | Partially aligned in bacteriophage and lyotrophic alcohol medium.
|
Resolution not provided
|
|
2QMT
Crystal Polymorphism of Protein GB1 Examined by Solid-state NMR and X-ray Diffraction
Deposited 2007-07-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
Fragment:immunoglobulin beta 1 binding domain (residues 303-357)
|
Mutation:T2Q
|
PO4 PHOSPHATE ION × 1
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
IPA ISOPROPYL ALCOHOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;277 K;50 mM NaCl, 50% MPD, 6% IPA, 25 mM Acetate, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.05 Å
R-free 0.207
|
|
3FIL
Structural and energetic determinants for hyperstable variants of GB1 obtained from in-vitro evolution
Deposited 2008-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
303–357(55 aa)
Fragment:immunoglobulin binding domain, UNP residues 303-357
Chain B
303–357(55 aa)
Fragment:immunoglobulin binding domain, UNP residues 303-357
|
Mutation:T2Q, E15V, T16L, T18I, N37L
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:T2Q, E15V, T16L, T18I, N37L
|
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293.15 K;protein solution: 50mM sodium acetate pH 5.6, 50mg/ml protein. reservoir solution: 25% PEG 3350, 0.1M citric acids pH 3.5. Drop 400nl protein solution & 400nl reservoir solution, 80 micro-l reservoir, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K
|
Resolution 0.88 Å
R-free 0.149
|
|
3UI3
Structural and Biochemical Characterization of HP0315 from Helicobacter pylori as a VapD Protein with an Endoribonuclease Activity
Deposited 2011-11-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
304–357(54 aa)
Chain B
304–357(54 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.2M (NH4)2SO4, 9% PEG3350, 5-8% glycerol, 100mM 2-(N-morpholino)ethanesulfonic acid', pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.80 Å
R-free 0.284
|
|
3V3X
Nitroxide Spin Labels in Protein GB1: N8/K28 Double Mutant
Deposited 2011-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
304–357(54 aa)
Chain C
304–357(54 aa)
|
Mutation:C8N
Mutation:C8N
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 3
2PE NONAETHYLENE GLYCOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;150 mM sodium acetate pH 4.5, 18% w/v PEG 3350 , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å
R-free 0.288
|
|
3V3X
Nitroxide Spin Labels in Protein GB1: N8/K28 Double Mutant
Deposited 2011-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain B
304–357(54 aa)
Chain D
304–357(54 aa)
|
Mutation:C8N
Mutation:C8N
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 4
GOL GLYCEROL × 1
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;150 mM sodium acetate pH 4.5, 18% w/v PEG 3350 , VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.00 Å
R-free 0.288
|
|
4WH4
Protein GB1 Quadruple Mutant I6H/N8H/K28H/Q32H
Deposited 2014-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Mutation:I6H/N8H/K28H/Q32H
|
SO4 SULFATE ION × 1
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;1.75 M ammonium sulfate, 0.2 M sodium chloride, 0.1 M HEPES pH 7.5
|
Resolution 2.20 Å
R-free 0.256
|
|
4WH4
Protein GB1 Quadruple Mutant I6H/N8H/K28H/Q32H
Deposited 2014-09-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
304–357(54 aa)
|
Mutation:I6H/N8H/K28H/Q32H
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;1.75 M ammonium sulfate, 0.2 M sodium chloride, 0.1 M HEPES pH 7.5
|
Resolution 2.20 Å
R-free 0.256
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 2
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMG
Nitroxide Spin Labels in Protein GB1: E15 Mutant
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:E15C
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;298 K;0.1 M magnesium chloride, 0.1 M Tris pH 4.5, 20% w/v PEG 4000
|
Resolution 2.20 Å
R-free 0.218
|
|
5BMH
Nitroxide Spin Labels in Protein GB1: T44 Mutant, Crystal Form B
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:T44C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;298 K;0.2 M potassium sodium tartrate, 0.2 M sodium citrate pH 6.0, 2 M ammonium sulfate
|
Resolution 1.60 Å
R-free 0.175
|
|
5BMI
Nitroxide Spin Labels in Protein GB1: T44 Mutant, Crystal Form A
Deposited 2015-05-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
Fragment:UNP residues 304-357
|
Mutation:T44C
|
MTN S-[(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl] methanesulfonothioate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;298 K;0.1 M HEPES pH 7.5, 1.2 M sodium citrate
|
Resolution 2.50 Å
R-free 0.251
|
|
5HFY
Backbone Modifications in the Protein GB1 Helix: beta-2-Ala24, beta-3-Lys28, beta-3-Lys31, beta-3-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2 M sodium acetate pH 4.6, 20% w/v PEG 4000
|
Resolution 1.95 Å
R-free 0.230
|
|
5HFY
Backbone Modifications in the Protein GB1 Helix: beta-2-Ala24, beta-3-Lys28, beta-3-Lys31, beta-3-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;298 K;0.2 M sodium acetate pH 4.6, 20% w/v PEG 4000
|
Resolution 1.95 Å
R-free 0.230
|
|
5HG2
Backbone Modifications in the Protein GB1 Helix: beta-3-Ala24, beta-3-Lys28, beta-3-Lys31, beta-2-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1 M sodium cacodylate pH 6.5, 0.1 M magnesium acetate, 20% w/v PEG 4000
|
Resolution 1.80 Å
R-free 0.216
|
|
5HG2
Backbone Modifications in the Protein GB1 Helix: beta-3-Ala24, beta-3-Lys28, beta-3-Lys31, beta-2-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1 M sodium cacodylate pH 6.5, 0.1 M magnesium acetate, 20% w/v PEG 4000
|
Resolution 1.80 Å
R-free 0.216
|
|
5HG2
Backbone Modifications in the Protein GB1 Helix: beta-3-Ala24, beta-3-Lys28, beta-3-Lys31, beta-2-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1 M sodium cacodylate pH 6.5, 0.1 M magnesium acetate, 20% w/v PEG 4000
|
Resolution 1.80 Å
R-free 0.216
|
|
5HG2
Backbone Modifications in the Protein GB1 Helix: beta-3-Ala24, beta-3-Lys28, beta-3-Lys31, beta-2-Asn35
Deposited 2016-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
GOL GLYCEROL × 2
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;0.1 M sodium cacodylate pH 6.5, 0.1 M magnesium acetate, 20% w/v PEG 4000
|
Resolution 1.80 Å
R-free 0.216
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 7
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain G
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5HI1
Backbone Modifications in the Protein GB1 Helix: Aib24, beta-3-Lys28, beta-3-Lys31, Aib35
Deposited 2016-01-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 8
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain H
302–357(56 aa)
Fragment:UNP residues 302-357
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;0.2 M ammonium sulfate, 0.1M sodium acetate pH 4.5, 20% (w/v) PEG 4000
|
Resolution 2.15 Å
R-free 0.252
|
|
5UB0
Solution NMR Structure of NERD-C, a natively folded tetramutant of the B1 domain of streptococcal protein G (GB1)
Deposited 2016-12-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:UNP residues 373-427
|
Mutation:Y3F/L7I/F30L/V39I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 10 mM sodium phosphate;Pressure 1
NMR sample composition
1.0 mM [U-98% 15N] protein (GB1), 10 mM sodium phosphate, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100% D2O | 100% D2O
|
Resolution not provided
|
|
5UBS
Solution NMR Structure of NERD-S, a natively folded pentamutant of the B1 domain of streptococcal protein G (GB1) with a solvent-exposed Trp43
Deposited 2016-12-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:UNP residues 373-427
|
Mutation:Y3F/L7I/A34F/V39L/V54I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 10 mM sodium phosphate;Pressure 1
NMR sample composition
1 mM [U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 100% D2O | 100% D2O
|
Resolution not provided
|
|
5UCE
Solution NMR structure of the major species of DANCER-2, a dynamic and natively folded pentamutant of the B1 domain of streptococcal protein G (GB1)
Deposited 2016-12-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:UNP residues 373-427
|
Mutation:Y3F/L5A/L7I/A34F/V39L
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 10 mM sodium phosphate;Pressure 1
NMR sample composition
200 uM [U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O, 10% D2O | 90% H2O/10% D2O
NMR sample composition
200 uM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
200 uM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 100% D2O | 100% D2O
|
Resolution not provided
|
|
5UCF
Solution NMR-derived model of the minor species of DANCER-2, a dynamic and natively folded pentamutant of the B1 domain of streptococcal protein G (GB1)
Deposited 2016-12-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:UNP residues 373-427
|
Mutation:Y3F/L5A/L7I/A34F/V39L
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 10 mM sodium phosphate;Pressure 1
NMR sample composition
200 uM [U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
200 uM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 100% D2O | 100% D2O
NMR sample composition
200 uM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100 uM EDTA, 0.02 % sodium azide, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6C9O
Selenomethionine mutant (V29Sem) of protein GB1 examined by X-ray diffraction
Deposited 2018-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Mutation:V29M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;283.15 K;46% MPD, 20% IPA, 25 mM sodium acetate pH 4.5
|
Resolution 1.20 Å
R-free 0.179
|
|
6C9O
Selenomethionine mutant (V29Sem) of protein GB1 examined by X-ray diffraction
Deposited 2018-01-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
304–357(54 aa)
|
Mutation:V29M
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;283.15 K;46% MPD, 20% IPA, 25 mM sodium acetate pH 4.5
|
Resolution 1.20 Å
R-free 0.179
|
|
6CHE
Selenomethionine mutant (A34Sem) of protein GB1 examined by X-ray diffraction
Deposited 2018-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Mutation:A34Sem
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.9;283.15 K;49% MPD
20% IPA
25 mM sodium acetate pH 4.9
20 mg/ml protein in 25 mM sodium acetate buffer pH 5.5 and 2 mM TCEP
|
Resolution 1.10 Å
R-free 0.147
|
|
6CPZ
Selenomethionine mutant (I6Sem) of protein GB1 examined by X-ray diffraction
Deposited 2018-03-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Mutation:I6Sem
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;283.15 K;48% MPD
20% IPA
25 mM sodium acetate buffer pH 4.7
20 mg/ml protein in 25 mM sodium acetate buffer pH 5.5 and 2 mM TCEP
|
Resolution 1.12 Å
R-free 0.156
|
|
6CPZ
Selenomethionine mutant (I6Sem) of protein GB1 examined by X-ray diffraction
Deposited 2018-03-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
304–357(54 aa)
|
Mutation:I6Sem
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;283.15 K;48% MPD
20% IPA
25 mM sodium acetate buffer pH 4.7
20 mg/ml protein in 25 mM sodium acetate buffer pH 5.5 and 2 mM TCEP
|
Resolution 1.12 Å
R-free 0.156
|
|
6CTE
77Se-NMR probes the protein environment of selenomethionine
Deposited 2018-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Mutation:V39Sem
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 2
PO4 PHOSPHATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;283.15 K;49% MPD
20% IPA
25 mM sodium acetate pH 4.7
20 mg/ml protein concentration
25 mM sodium acetate pH 5.5
non-reducing
|
Resolution 1.20 Å
R-free 0.175
|
|
6CTE
77Se-NMR probes the protein environment of selenomethionine
Deposited 2018-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
304–357(54 aa)
|
Mutation:V39Sem
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
PO4 PHOSPHATE ION × 3
MRD (4R)-2-METHYLPENTANE-2,4-DIOL × 1
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.7;283.15 K;49% MPD
20% IPA
25 mM sodium acetate pH 4.7
20 mg/ml protein concentration
25 mM sodium acetate pH 5.5
non-reducing
|
Resolution 1.20 Å
R-free 0.175
|
|
6HKA
The solution structure of the micelle-associated FATC domain of the human protein kinase ataxia telangiectasia mutated (ATM)
Deposited 2018-09-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5;298 K;Ionic strength (raw mmCIF value) 100;Pressure 1
NMR sample composition
100 mM sodium chloride, 50 mM TRIS, 150 mM [U-100% 2H] DPC, 0.4 mM [U-100% 13C; U-100% 15N] 13C-15N-hATMfatc, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
100 mM sodium chloride, 50 mM TRIS, 150 mM [U-100% 2H] DPC, 0.4 mM [U-10% 13C] 13C-hATMfatc, 95% H2O/5% D2O | 95% H2O/5% D2O
NMR sample composition
100 mM sodium chloride, 50 mM TRIS, 150 mM [U-100% 2H] DPC, 0.5 mM [U-100% 15N] 15N-hATMfatc, 95% H2O/5% D2O | 95% H2O/5% D2O
|
Resolution not provided
|
|
6HPJ
Structure of human SRSF1 RRM1 bound to AACAAA RNA
Deposited 2018-09-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: dimeric
|
Chain B
304–357(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;313 K;Ionic strength (raw mmCIF value) 120;Pressure atmospheric
NMR sample composition
0.5 mM [U-99% 15N] SRSF1 RRM1, 0.5 mM RNA (5'-R(*AP*AP*CP*AP*AP*A)-3'), 100% D2O | 100% D2O
NMR sample composition
0.5 mM [U-99% 15N] SRSF1 RRM1, 0.5 mM NA RNA (5'-R(*AP*AP*CP*AP*AP*A)-3'), 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
0.5 mM [U-99% 13C; U-99% 15N] SRSF1 RRM1, 0.5 mM NA RNA (5'-R(*AP*AP*CP*AP*AP*A)-3'), 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
6NJF
Solution NMR Structure of DANCER3-F34A, a rigid and natively folded single mutant of the dynamic protein DANCER-3
Deposited 2019-01-03
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
373–427(55 aa)
Fragment:residues 373-427
|
Mutation:Y3F, V7I, V39L, V54I
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7.4;298 K;Ionic strength (raw mmCIF value) 10 mM sodium phosphate;Pressure 1
NMR sample composition
1.0 mM [U-98% 15N] protein (GB1), 10 mM sodium phosphate, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 90% H2O/10% D2O | 90% H2O/10% D2O
NMR sample composition
1.0 mM [U-99% 13C; U-98% 15N] protein (GB1), 10 mM sodium phosphate, 100% D2O | 100% D2O
|
Resolution not provided
|
|
6NL6
Crystal structure of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, N35K, D36H, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, D36H, N35K, D36A, N37Q
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;70 mM acetic Acid pH 3.6, 30 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 100 mM NaCl, and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.214
|
|
6NL6
Crystal structure of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, N35K, D36H, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Mutation:T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, D36H, N35K, D36A, N37Q
|
ZN ZINC ION × 3
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;70 mM acetic Acid pH 3.6, 30 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 100 mM NaCl, and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.214
|
|
6NL6
Crystal structure of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, N35K, D36H, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
303–357(55 aa)
|
Mutation:T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, D36H, N35K, D36A, N37Q
|
ZN ZINC ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;70 mM acetic Acid pH 3.6, 30 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 100 mM NaCl, and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.214
|
|
6NL6
Crystal structure of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, N35K, D36H, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
303–357(55 aa)
|
Mutation:T16F, T18A, V21E, T25L, K28Y, V29I, K31R, Q32H, Y33L, D36H, N35K, D36A, N37Q
|
ZN ZINC ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;70 mM acetic Acid pH 3.6, 30 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 100 mM NaCl, and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.214
|
|
6NL7
Crystal structure of B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q
|
ZN ZINC ION × 2
ACT ACETATE ION × 2
NA SODIUM ION × 2
CL CHLORIDE ION × 1
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;80 mM acetic acid pH 3.6, 20 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 200 mM NaCl and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.158
|
|
6NL7
Crystal structure of B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Mutation:T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q
|
ZN ZINC ION × 2
ACT ACETATE ION × 3
NA SODIUM ION × 1
PO4 PHOSPHATE ION × 1
DPO DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;80 mM acetic acid pH 3.6, 20 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 200 mM NaCl and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.158
|
|
6NL7
Crystal structure of B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
303–357(55 aa)
|
Mutation:T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q
|
ACT ACETATE ION × 2
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;80 mM acetic acid pH 3.6, 20 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 200 mM NaCl and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.158
|
|
6NL7
Crystal structure of B1 immunoglobulin-binding domain of Streptococcal Protein G (T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q)
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
303–357(55 aa)
|
Mutation:T16F, T18A, V21H, T25H, K28Y, V29I, K31R, Q32A, Y33L, N35K, D36A, N37Q
|
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;80 mM acetic acid pH 3.6, 20 mM acetic acid pH 5.8, 30% 2,4-methylpentanediol, 200 mM NaCl and 20 mM zinc sulfate
|
Resolution 1.40 Å
R-free 0.158
|
|
6NL8
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, T16L, V29H, Y33H, N37L)-zinc
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
303–357(55 aa)
|
Mutation:L12H, T16L, V29H, Y33H, N37L
|
ZN ZINC ION × 4
CL CHLORIDE ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;18.5% PEG 400 0.1M HEPES pH 7.5
50 mM MgCl2, 5mM zinc sulfate
|
Resolution 1.50 Å
R-free 0.163
|
|
6NL9
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, T16L, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:L12H, T16L, V29H, Y33H, N37L
|
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;30% PEG 4000 0.1M HEPES pH 7.5
200 mM MgCl2
|
Resolution 1.70 Å
R-free 0.224
|
|
6NL9
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, T16L, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Mutation:L12H, T16L, V29H, Y33H, N37L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;30% PEG 4000 0.1M HEPES pH 7.5
200 mM MgCl2
|
Resolution 1.70 Å
R-free 0.224
|
|
6NL9
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, T16L, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
303–357(55 aa)
|
Mutation:L12H, T16L, V29H, Y33H, N37L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;30% PEG 4000 0.1M HEPES pH 7.5
200 mM MgCl2
|
Resolution 1.70 Å
R-free 0.224
|
|
6NL9
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, T16L, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
303–357(55 aa)
|
Mutation:L12H, T16L, V29H, Y33H, N37L
|
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;30% PEG 4000 0.1M HEPES pH 7.5
200 mM MgCl2
|
Resolution 1.70 Å
R-free 0.224
|
|
6NLA
Crystal structure of de novo designed metal-controlled dimer of B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, E15V, T16L, T18I, V29H, Y33H, N37L)-zinc
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
303–357(55 aa)
|
Mutation:L12H, E15V, T16L, T18I, V29H, Y33H, N37L
|
ZN ZINC ION × 4
CL CHLORIDE ION × 6
GOL GLYCEROL × 2
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;4M NaCl 0.1M HEPES pH 7.5
50mM MgCl2, 5mM zinc sulfate
|
Resolution 1.34 Å
R-free 0.128
|
|
6NLB
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, E15V, T16L, T18I, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:L12H, E15V, T16L, T18I, V29H, Y33H, N37L
|
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;31% PEG 4,000 0.1M Tris pH 8.5
200mM MgCl2
|
Resolution 2.30 Å
R-free 0.258
|
|
6NLB
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, E15V, T16L, T18I, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Mutation:L12H, E15V, T16L, T18I, V29H, Y33H, N37L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;31% PEG 4,000 0.1M Tris pH 8.5
200mM MgCl2
|
Resolution 2.30 Å
R-free 0.258
|
|
6NLB
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, E15V, T16L, T18I, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
303–357(55 aa)
|
Mutation:L12H, E15V, T16L, T18I, V29H, Y33H, N37L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;31% PEG 4,000 0.1M Tris pH 8.5
200mM MgCl2
|
Resolution 2.30 Å
R-free 0.258
|
|
6NLB
Crystal structure of de novo designed metal-controlled dimer of mutant B1 immunoglobulin-binding domain of Streptococcal Protein G (L12H, E15V, T16L, T18I, V29H, Y33H, N37L)-apo
Deposited 2019-01-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
303–357(55 aa)
|
Mutation:L12H, E15V, T16L, T18I, V29H, Y33H, N37L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;298 K;31% PEG 4,000 0.1M Tris pH 8.5
200mM MgCl2
|
Resolution 2.30 Å
R-free 0.258
|
|
6O41
Crystal structure of the unbound PGZL1 germline Fab fragment (PGZL1_gVmDmJ)
Deposited 2019-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain M
438–497(60 aa)
|
Not recorded
|
GOL GLYCEROL × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% PEG3350, 0.2 M lithium citrate
|
Resolution 2.46 Å
R-free 0.219
|
|
6O41
Crystal structure of the unbound PGZL1 germline Fab fragment (PGZL1_gVmDmJ)
Deposited 2019-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain O
438–497(60 aa)
|
Not recorded
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% PEG3350, 0.2 M lithium citrate
|
Resolution 2.46 Å
R-free 0.219
|
|
6O41
Crystal structure of the unbound PGZL1 germline Fab fragment (PGZL1_gVmDmJ)
Deposited 2019-02-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain N
438–497(60 aa)
|
Not recorded
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% PEG3350, 0.2 M lithium citrate
|
Resolution 2.46 Å
R-free 0.219
|
|
6OC7
HMP42 Fab in complex with Protein G
Deposited 2019-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
438–497(60 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;293 K;17% PEG 4000, 15% glycerol, 8.5% 2-propanol and 85 mM HEPES pH 7.5
|
Resolution 1.30 Å
R-free 0.184
|
|
6UUH
Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11
Deposited 2019-10-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain E
438–497(60 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.085M sodium acetate (pH=4.0), 0.17M ammonium acetate, 5% %(v/v) glycerol, 27.882 %(w/v) PEG4000, 15% glycerol
|
Resolution 2.70 Å
R-free 0.260
|
|
6UUH
Crystal structure of broad and potent HIV-1 neutralizing antibody 438-B11
Deposited 2019-10-30
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Other combination
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain F
438–497(60 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.085M sodium acetate (pH=4.0), 0.17M ammonium acetate, 5% %(v/v) glycerol, 27.882 %(w/v) PEG4000, 15% glycerol
|
Resolution 2.70 Å
R-free 0.260
|
|
6UYG
Structure of Hepatitis C Virus Envelope Glycoprotein E2c3 core from genotype 6a bound to broadly neutralizing antibody AR3A and non neutralizing antibody E1
Deposited 2019-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain G
438–497(60 aa)
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.2M magnesium chloride, 10% (w/v) PEG 3000, 15% ethylene glycol, 0.1M Na-cacodylate, pH=6.5
|
Resolution 3.38 Å
R-free 0.305
|
|
6W00
Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein
Deposited 2020-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
440–497(58 aa)
Fragment:domain III (UNP residues 438-497)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;0.2 M sodium chloride, 20% w/v PEG3350
|
Resolution 1.85 Å
R-free 0.206
|
|
6WFW
Crystal structure of Fab364 in complex with NPNA2 peptide from circumsporozoite protein
Deposited 2020-04-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
439–497(59 aa)
Fragment:domain III (UNP residues 438-497)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;277.15 K;20% PEG8000, 0.05 M potassium phosphate dibasic
|
Resolution 2.09 Å
R-free 0.257
|
|
7DA8
X-ray structure of a GB1:T2Q/D46K mutant
Deposited 2020-10-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Mutation:T303Q, D347K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;MES monohydrate pH 6.5 (buffer system 1), 40% v/v PEG 500* MME, 20 % w/v PEG 20000 (Precipitant mix1) (Morpheus Screen ID 25).
|
Resolution 2.40 Å
R-free 0.305
|
|
8DIJ
NMR Structure of Streptococcal Protein GB1 Backbone Modified Variant: beta-ACPC24, beta-3-Lys28, beta-3-Lys31, beta-ACPC35
Deposited 2022-06-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
302–357(56 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 40;Pressure 1
NMR sample composition
0.65 mM Streptococcal Protein GB1 Backbone Modified Variant: beta-ACPC24, beta-3-Lys28, beta-3-Lys31, beta-ACPC35, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8TFR
Apo Fab from C10-S66K antibody
Deposited 2023-07-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
438–497(60 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293.15 K;20% PEG 3350, 0.2 M Na3-citrate, pH 8.2
|
Resolution 2.99 Å
R-free 0.262
|
|
8UM7
Site-specific Aspartic Acid Dehydration and Isomerization in Streptococcal Protein GB1: Wild-type Protein
Deposited 2023-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 41;Pressure 1
NMR sample composition
0.12 mM B1 Domain of Streptococcal Protein G, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8UM9
Site-specific Aspartic Acid Dehydration and Isomerization in Streptococcal Protein GB1: D-Asp40 Variant
Deposited 2023-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 41;Pressure 1
NMR sample composition
0.12 mM B1 Domain of Streptococcal Protein G, D-Asp40 Variant, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8UMA
Site-specific Aspartic Acid Dehydration and Isomerization in Streptococcal Protein GB1: D-isoAsp40 Variant
Deposited 2023-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 41;Pressure 1
NMR sample composition
0.17 mM B1 Domain of Streptococcal Protein G, D-isoAsp40 Variant, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8UMB
Site-specific Aspartic Acid Dehydration and Isomerization in Streptococcal Protein GB1: L-Aspartyl Succinimide 40-41 Variant
Deposited 2023-10-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 41;Pressure 1
NMR sample composition
0.07 mM B1 Domain of Streptococcal Protein G, L-Aspartyl Succinimide 40-41 Variant, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8UMS
Site-specific Aspartic Acid Dehydration and Isomerization in Streptococcal Protein GB1: L-isoAsp40 Variant
Deposited 2023-10-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
304–357(54 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 7;298 K;Ionic strength (raw mmCIF value) 41;Pressure 1
NMR sample composition
0.18 mM B1 Domain of Streptococcal Protein G, L-isoAsp40 Variant, 20 mM sodium phosphate, 0.1 mM DSS, 90% H2O/10% D2O | 90% H2O/10% D2O
|
Resolution not provided
|
|
8WCJ
Crystal structure of GB3 penta mutation L5V/K10H/T16S/K19E/Y33I
Deposited 2023-09-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
444–497(54 aa)
|
Mutation:L446V, K451H, T457S, K460E, Y474I
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7;293 K;60% v/v Tacsimate pH 7.0
|
Resolution 1.55 Å
R-free 0.233
|
|
9AWE
The crystal structure of an engineered Protein GF with Human Kappa Fab
Deposited 2024-03-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
368–430(63 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.1M Sodium Cacodylate pH 6.0, 0.1M Calcium acetate hydrate, 10% PEG 8000
|
Resolution 2.80 Å
R-free 0.293
|
|
9BDE
Middle Region of Apolipoprotein B 100 bound to Low Density Lipoprotein Receptor
Deposited 2024-04-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
440–497(58 aa)
Fragment:;residues 27-384 (Uniprot numbering),residues 278-327 (Uniprot numbering),103-151 (Uniprot numbering),residues 440-497 (Uniprot numbering)
;
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 5
CA CALCIUM ION × 7
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.18 Å
|
|
9I2I
X-ray structure of the B1 domain of streptococcal protein G triple mutant T2Q, N8D, and N37D (GB1-QDD).
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;278 K;50% MPD, 25% isopropyl alcohol,
|
Resolution 1.08 Å
R-free 0.210
|
|
9I2I
X-ray structure of the B1 domain of streptococcal protein G triple mutant T2Q, N8D, and N37D (GB1-QDD).
Deposited 2025-01-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;278 K;50% MPD, 25% isopropyl alcohol,
|
Resolution 1.08 Å
R-free 0.210
|
|
9QBJ
Legobody dimer
Deposited 2025-03-03
|
Different construct
Different oligomeric state
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain I
440–496(57 aa)
Chain J
440–497(58 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9T8Z
Room temperature X-ray structure of the B1 domain of streptococcal protein G triple mutant T2Q, N8D, and N37D (GB1-QDD).
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
303–357(55 aa)
|
Not recorded
|
NA SODIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;278 K;50 % 2-methyl-2,4-pentanediol (MPD), 25 % isopropanol
|
Resolution 1.69 Å
R-free 0.197
|
|
9T8Z
Room temperature X-ray structure of the B1 domain of streptococcal protein G triple mutant T2Q, N8D, and N37D (GB1-QDD).
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
303–357(55 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICRODIALYSIS;278 K;50 % 2-methyl-2,4-pentanediol (MPD), 25 % isopropanol
|
Resolution 1.69 Å
R-free 0.197
|